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Genome-wide association studies (GWASs) primarily performed in European-ancestry (EA) populations have identified numerous loci
associated with body mass index (BMI). However, it is still unclear whether these GWAS loci can be generalized to other ethnic groups,
such as African Americans (AAs). Furthermore, the putative functional variant or variants in these loci mostly remain under investiga-
tion. The overall lower linkage disequilibrium in AA compared to EA populations provides the opportunity to narrow in or fine-map
these BMI-related loci. Therefore, we used the Metabochip to densely genotype and evaluate 21 BMI GWAS loci identified in EA studies
in 29,151 AAs from the Population Architecture usingGenomics and Epidemiology (PAGE) study. Eight of the 21 loci (SEC16B, TMEM18,
ETV5, GNPDA2, TFAP2B, BDNF, FTO, andMC4R) were found to be associated with BMI in AAs at 5.8 3 105. Within seven out of these
eight loci, we found that, on average, a substantially smaller number of variants was correlated (r2> 0.5) with themost significant SNP in
AA than in EA populations (16 versus 55). Conditional analyses revealed GNPDA2 harboring a potential additional independent signal.
Moreover, Metabochip-wide discovery analyses revealed two BMI-related loci, BRE (rs116612809, p ¼ 3.6 3 108) and DHX34
(rs4802349, p ¼ 1.2 3 107), which were significant when adjustment was made for the total number of SNPs tested across the chip.
These results demonstrate that fine mapping in AAs is a powerful approach for both narrowing in on the underlying causal variants
in known loci and discovering BMI-related loci.Introduction
Obesity (MIM 601665) is amajor risk factor for a number of
chronic diseases, such as type 2 diabetes (MIM 125853),
hyperlipidemia (MIM 144250), cardiovascular diseases,
and several cancer types.1,2 Worldwide obesity prevalence
has nearly doubled since 1980, and in 2008 more than
1.4 billion adults worldwide were obese. In the United
States, more than one-third of adults (35.7%) were obese
in 2010.
Studies have shown that obesity is highly heritable; her-
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be time and labor intensive. In addition, dense genotyping
of the GWAS loci could aid the discovery of additional
independent signals within the GWAS loci.
In this study, we densely genotyped 21 BMI loci identi-
fied in EA studies in 29,151 AAs from the Population
Architecture using Genomics and Epidemiology (PAGE)
consortium by using the Metabochip.9 We aimed to fine-
map the 21 known BMI loci in the AA population and
search for additional independent signals associated with
BMI. For validated loci in AAs, we evaluated whether
weaker LD patterns in AAs can help narrow in on the
underlying potential causal variants. In addition, because
Metabochip was developed to test putative association sig-
nals for BMI and many obesity-related metabolic and
cardiovascular traits and to fine-map established loci,9 we
also conducted a Metabochip-wide discovery-oriented
analysis to search for potential BMI-associated loci.Subjects and Methods
Study Population
The National Human Genome Research Institute funds the PAGE
consortium to investigate the epidemiologic architecture of well-
replicated genetic variants associated with human diseases or
traits.10 PAGE consists of a coordinating center and four consortia,
Epidemiologic Architecture for Genes Linked to Environment
(EAGLE), which is uses data from Vanderbilt University Medical
Center’s biorepository and links it to deidentified electronic med-
ical records (BioVU); the Multiethnic Cohort Study (MEC); the
Women’s Health Initiative (WHI); and Causal Variants Across
the Life Course (CALiCo), itself a consortium of five cohort
studies—the Atherosclerosis Risk in Communities (ARIC) study,
Coronary Artery Risk Development in Young Adults (CARDIA),
the Cardiovascular Health Study (CHS), the Hispanic Community
Health Study/Study of Latinos, and the Strong Heart Study.10
This PAGEMetabochip study included AA participants from the
ARIC, BioVU, CHS, CARDIA, MEC, and WHI studies and from
extended collaborations to two additional studies – GenNet and
the Hypertension Genetic Epidemiology Network (HyperGen)
(Table S1, in the Supplemental Data available with this article
online). The detailed description of each study can be found in
the Supplemental Data. We excluded underweight (BMI <
18.5 kg/m2) and extremely overweight (BMI > 70 kg/m2) individ-
uals under the assumption that these extremes could be attribut-
able to data-coding errors or an underlying rare condition outside
the scope of this investigation. We also limited analysis to adults
(defined as having an age > 20 years). The CARDIA participants
are young, and the BMI< 18.5 exclusion criterion was not applied
in this cohort. All studies were approved by institutional review
boards at their respective sites, and all study participants provided
informed consent.Anthropometric Measurements
For individuals from the ARIC, CHS, CARDIA, HyperGEN,
GenNet, and WHI studies, BMI was calculated from height and
weight measured at the time of study enrollment. For individuals
from BioVU, the median height and weight across all visit years
were used in BMI calculations. For individuals from MEC, self-re-
ported height and weight were used for calculations of baseline662 The American Journal of Human Genetics 93, 661–671, OctoberBMI. A validation study within MEC has shown high validity of
self-reported height and weight. Specifically, this study showed
that BMI was underestimated on the basis of self-reports versus
measured weight, but the difference was small (< 1 BMI unit)
and was comparable to the findings from national surveys.11Genotyping and Quality Control
Genotyping was performed with the Metabochip, whose design
has been described elsewhere.9 In brief, the Metabochip, a custom
Illumina iSelect genotyping array of nearly 200,000 SNP markers,
is designed to cost-effectively analyze putative association signals
identified through GWAS meta-analyses of many obesity-related
metabolic and cardiovascular traits and to fine-map established
loci.9 Metabochip SNPs were selected from the catalogs developed
by the International HapMap and 1000 Genomes projects.9 More
than 122,000 SNPs were included for fine mapping of 257 GWAS
loci of 23 traits (including 21 BMI loci).9 For determination of the
boundaries around each GWAS index SNP, all SNPs with r2R 0.5
with the index SNP were identified, and then initial boundaries
were expanded by 0.02 cM in either direction through use of the
HapMap-based genetic map. SNPs were excluded if (1) the Illu-
mina design score was<0.5 or (2) SNPs within 15 bp in both direc-
tions of the SNP of interest could be foundwith an allele frequency
of >0.02 among Europeans (CEU). SNPs annotated as nonsynon-
ymous, essential splice site, or stop codonwere included regardless
of allele frequency, design score, or nearby SNPs in the primer.9
Twenty-one BMI GWAS loci identified at the time at which the
Metabochip was designed were represented for signal fine map-
ping (Table S2).
Samples were genotyped at the Human Genetics Center of the
University of Texas, Houston (ARIC, CHS, CARDIA, GenNet, and
HyperGEN), the Vanderbilt DNA Resources Core in Nashville
(BioVU), the University of Southern California Epigenome Center
(MEC), and the Translational Genomics Research Institute (WHI).
Each center genotyped the same 90 HapMap YRI (Yoruba in Iba-
dan, Nigeria) samples to facilitate cross-study quality control
(QC), as well as 2%–3% study-specific blinded replicates to assess
genotyping quality. Genotypes were called separately for each
study via GenomeStudio with the GenCall 2.0 algorithm. Study-
specific cluster definitions (based on samples with call rate >
95%; ARIC, BioVU, CHS, CARDIA, MEC, and WHI) or cluster
definitions provided by Illumina (GenNet and HyperGEN) were
used for sample calling, and samples were kept in the analysis if
the call rate was >95%. We excluded SNPs with a GenTrain score
<0.6 (ARIC, BioVU, CHS, CARDIA, MEC, and WHI) or <0.7
(GenNet and HyperGEN), a cluster separation score <0.4, a call
rate <0.95, and a Hardy-Weinberg equilibrium p <1 3 106. We
utilized the common 90 YRI samples and excluded any SNP that
had more than 1 Mendelian error (in 30 YRI trios), any SNP that
had more than two replication errors with discordant calls when
comparisons were made across studies in 90 YRI samples, and
any SNP that had more than three discordant calls for 90 YRI
genotyped in PAGE versus the HapMap database. SNPs were
excluded from the meta-analyses if they were present in less
than three studies.
For ARIC, BioVU, CHS, CARDIA, MEC, and WHI combined we
identified related individuals by using PLINK to estimate iden-
tical-by-descent (IBD) statistics for all pairs. When apparent pairs
of first-degree relatives were identified, we excluded from each
pair the member with the lower call rate. We excluded from
further analysis samples with an inbreeding coefficient (F) above3, 2013
0.15 (ARIC, BioVU, CHS, CARDIA, MEC, and WHI).12 We deter-
mined principal components of ancestry in each study separately
by using EIGENSOFT13,14 and excluded apparent ancestral outliers
from further analysis as described elsewhere.15WHI SHARe Imputation
Of the WHI women genotyped on the Metabochip, 1,962 women
were part of the group of 8,288 WHI subjects genotyped for the
WHI SNP Health Association Resource (SHARe) GWAS via the
Affymetrix 6.0 platform. To improve statistical power, we imputed
the Metabochip SNPs in the remaining 6,326 SHARe subjects with
Affymetrix 6.0 data. Details can be found elsewhere.16 In brief, we
first merged genotypes for the 1,962 subjects genotyped on both
the Affymetrix 6.0 platform and the Metabochip and constructed
haplotypes (study-specific reference panel). We then phased the
haplotypes for samples genotyped on the Affymetrix 6.0 platform
only and performed a haplotype-to-haplotype imputation on
Metabochip SNPs for the 6,326 target individuals to estimate ge-
notypes (as allele dosages). We used MACH for phasing and Mini-
mac for final imputation. To evaluate the quality of each imputed
SNP, we calculated the dosage r2. We excluded imputed SNPs with
r2 < 0.5 for SNPs with allele frequency < 1% and with r2 < 0.3 for
SNPs with allele frequency > 1%. Given the large reference panel
and strict QC criteria, this resulted in high imputation quality.16Statistical Analysis
In each study, we evaluated the association between natural-log-
transformed BMI and each SNP. Because the distribution of BMI
was not normal (it was skewed toward higher BMI), we used natu-
ral-log-transformed BMI,17 which reduces the influence of poten-
tial outlying observations on the analyses. Except for GenNet and
HyperGen, linear regression models were used under the assump-
tion of an additive genetic model and with the adjustment for age,
sex, study site (as applicable), and ancestry principal components
in each study. All models (except WHI) included the interaction
term of sex and age so that possible effect modification by sex
was accounted for. Family data from GenNet and HyperGen
were analyzed with linear mixed models so that relatedness was
accounted for. We used fixed-effect models with inverse variance
weighting to pool the study-specific association results as imple-
mented in METAL.18 We used Q-statistics and I2 to measure het-
erogeneity across studies. To determine whether the 21 previously
identified GWAS loci were significantly associated with BMI in AA,
we used the p value threshold 5.8 3 105 as an approximate
correction for an average of 866 SNPs at each locus (i.e., 0.05/
866 SNPs).19 To identify additional independent signals in any
of the loci that were significantly associated with BMI in our study,
we conducted conditional analyses. We performed linear regres-
sion models that included the most significant SNP (i.e., lead
SNP) as a covariate and each of the other SNPs at the same locus
(two SNPs in eachmodel) to search for additional independent sig-
nals. If, after adjustment for the lead SNP, any SNP remained sig-
nificant at the locus-specific Bonferroni-corrected significance
level (i.e., 0.05/number of SNPs tested at a given locus), we defined
the SNP as an additional independent signal. When testing all
other SNPs on the Metabochip, we used a Bonferroni-adjusted sig-
nificance level based on the total number of SNPs on the chip,
2.5 3 107 (0.05/200,000 SNPs), to declare a BMI-associated SNP.
No inflation was observed in any analysis (the inflation factor
l ¼ 1.00) in our Metabochip-wide analysis. For sex-stratified anal-The Americysis, GenNet and HyperGen were excluded because of the family-
study design.
LD in the AA sample was calculated in 500 kb sliding windows
via PLINK.20 Likewise, the Malmo Diet and Cancer Study on
2,143 controls from a Swedish population21 provided Metabochip
LD and frequency information in Europeans to facilitate the LD
pattern comparisons between AA and EA populations. We used
LocusZoom plots22 to graphically display the fine-mapping re-
sults. SNP positions from NCBI build 37 were used, and recombi-
nation rates were estimated from 1000 Genomes Project data.Functional Annotation
To inform the discussion about the underlying potential func-
tional variants, we made functional hypotheses for each of our
most significantly BMI-associated variants by compiling a list of
correlated SNPs (r2 > 0.5) genotyped in our AA study populations
and annotating each list for potential regulatory evidence consis-
tent with enhancers, promoters, insulators, silencers and other
effects related to gene expression. Because our lead SNPs and the
SNPs in strong LD with our lead SNPs were in noncoding regions,
we hypothesized that the underlying biology behind the signal
was likely to impact gene expression through some unknown reg-
ulatorymechanism. For each list we aligned correlated SNPs with a
combined browser view of all currently available ENCODE tracks
in the UCSC Genome Browser and compared each allelic region
for altered transcription factor binding site (TFBS) motifs by using
JASPAR and ConSite. Given that methylation patterns are highly
variable, it is useful to look for, in addition to BMI-relevant tissues,
histone modifications in many cell lines to identify regions that
are actively regulated, meaning that histone marks are present in
some but not all cell lines. Thus, in addition to adipocytes, hepa-
tocytes, and neurons, we used ENCODE’s histone modification
tracks to query a wide variety of cell lines for all available histone
marks to identify SNPs falling in various regulatory regions. The
DNase hypersensitivity track provided a more precise demarcation
of open chromatin loci, and the ChIP-Seq TFBS track provided
evidence for the binding of specific proteins. Although less specific
than ChIP-Seq, JASPAR, ConSite, and HaploReg databases were
used for querying a larger number of conserved TFBS and predict-
ing alterations in predictedmotifs between reference and alternate
alleles. A 46-way PhastCons track in the UCSC Genome Browser
was used as secondary evidence for a regulatory region, but lack
of conservation did not rule out a functional candidate. The
most likely functional-candidate SNPs for each locus were evalu-
ated for statistical significance in association with BMI. The
detailed list of functional annotation data sets we used is shown
in Table S3.Results
This study consisted of 29,151 AAs from eight studies.
Study participants had an average age of 51.2 years (Table
S1). Approximately 80% of study participants were
women. Within and across studies, men tended to have a
lower mean BMI than women. The obesity rate (BMI R
30 kg/m2) ranged from 16%–46% in men and 26%–64%
in women. After quality control, we tested 18,187 genetic
variants across 21 BMI loci and 177,663 variants across
the Metabochip.an Journal of Human Genetics 93, 661–671, October 3, 2013 663
Table 1. Association Results for the Most Significant SNP and All Previously Identified GWAS SNPs for Eight BMI-Related Loci with Significanta Results in African Americans
Region
Lead AA
SNP on
Metabochip
GWAS Index
SNP Position
Number of
SNPs
Candidate
Gene
R2 Lead SNP
with GWAS
SNP in AAs
R2 Lead SNP with
GWAS SNP in
EA Populations CAb
CAFc
in AAs
CAF in EA
Populations Effect p Value Rsqd Het P e I2
1q25.2 rs543874 rs543874 177889480 765 SEC16B - - T 0.75 0.81 0.0110 2.4 3 109 NA 0.04 0.52
2p25.3 rs6548240 - 636929 1,123 TMEM18 - - A 0.87 0.83 0.0130 1.1 3 107 0.98 0.96 0
- - rs6548238 634905 - TMEM18 0.86 0.99 A 0.12 0.17 0.0128 3.8 3 107 1.00 0.82 0
- - rs2867125 622827 - TMEM18 0.80 0.96 A 0.12 0.17 0.0114 5.6 3 106 1.00 0.79 0
- - rs7561317 644953 - TMEM18 0.49 0.99 A 0.24 0.17 0.0054 4.8 3 103 1.00 0.89 0
3q27.2 rs7647305 rs7647305 185834290 369 ETV5 - - A 0.41 0.23 0.0069 3.2 3 105 0.95 0.29 0.18
- - rs9816226 185834499 - ETV5 0.37 0.85 A 0.80 0.81 0.0067 9.1 3 104 0.96 0.57 0
4p12 rs10938397 rs10938397 45182527 342 GNPDA2 - - A 0.75 0.57 0.0099 1.7 3 107 0.99 0.24 0.23
6p12.3 rs2744475 - 50784880 1,685 TFAP2B - - C 0.67 0.71 0.0082 2.8 3 106 0.98 0.39 0.05
- - rs987237 50803050 - TFAP2B 0.23 0.50 A 0.90 0.82 0.0093 5.2 3 104 NA 0.07 0.46
11p14.1 rs1519480 - 27675712 688 BDNF - - A 0.25 0.68 0.0095 7.8 3 107 1.00 0.90 0
- - rs6265 27667202 - BDNF 0.14 0.12 A 0.05 0.18 0.0172 1.8 3 105 NA 0.64 0
- - rs925946 27679916 - BDNF 0.12 0.97 T 0.27 0.30 0.0005 7.9 3 101 1.00 0.23 0.24
- - rs10767664f 27724745 - BDNF 0.12 0.13 C 0.93 0.76 0.0111 3.7 3 104 0.99 0.28 0.18
16q12.2 rs62048402 - 53803223 1,814 FTO - - A 0.11 0.41 0.0120 5.1 3 106 1.00 0.14 0.34
- - rs1421085 53800954 - FTO 1.00 1.00 T 0.89 0.59 0.0119 6.5 3 106 NA 0.15 0.33
- - rs9930506 53830465 - FTO 0.44 0.81 T 0.79 0.57 0.0082 3.9 3 105 NA 0.21 0.27
- - rs9941349 53825488 - FTO 0.52 0.91g A 0.19 0.41 0.0082 1.1 3 104 NA 0.56 0
- - rs1558902 53803574 - FTO 0.98 1.00 A 0.88 0.58 0.0132 4.5 3 104 1.00 0.43 0
- - rs8050136 53816275 - FTO 0.15 0.94 A 0.43 0.41 0.0027 1.0 3 101 NA 0.05 0.48
- - rs9939609 53820527 - FTO 0.13 0.94 A 0.47 0.41 0.0027 1.0 3 101 1.00 0.10 0.40
- - rs1121980 53809247 - FTO 0.14 0.90 T 0.47 0.43 0.0021 1.9 3 101 NA 0.26 0.21
- - rs6499640 53769677 - FTO 0.00 0.09 A 0.65 0.60 0.0013 4.6 3 101 1.00 0.52 0
18q21.32 rs6567160 - 57829135 1275 MC4R - - A 0.81 0.75 0.0096 4.7 3 106 0.98 0.03 0.52
- - rs17782313 57851097 - MC4R 0.06 0.99 T 0.72 0.77 0.0068 1.5 3 104 1.00 0.50 0
- - rs10871777 57851763 - MC4R 0.05 0.97 A 0.71 0.75 0.0061 6.7 3 104 1.00 0.40 0.04
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The AmericFine Mapping BMI Loci
Among the 21 BMI GWAS loci identified in EA studies,
eight loci (SEC16B [MIM 612855], TMEM18 [MIM
613220], ETV5 [MIM 601600], GNPDA2 [MIM 613222],
TFAP2B [MIM 601601], BDNF [MIM 113505], FTO [MIM
610966], and MC4R [MIM 155541]) displayed SNPs with
significant evidence of association (Table 1; see also Table
S2). The lead SNP (the most significant SNP in AAs) in
each of these eight loci had a minor-allele frequency
>0.05 and showed little evidence of heterogeneity. In
these eight loci most GWAS index SNPs previously identi-
fied in EA GWASs (20 out of 23) had a consistent direction
of the effects reported in original EA studies. Because the
results of the FTO locus have been described previously,23
we focused on the other seven regions. Among those seven
loci, the lead SNPs, rs543874 in SEC16B (p ¼ 1.5 3 109),
rs7647305 in ETV5 (p ¼ 3.2 3 105), and rs10938397 in
GNPDA2 (p ¼ 1.7 3 107), were consistent with the previ-
ously identified GWAS SNP (the most significant SNP high-
lighted in the previous GWAS) in EA populations. For
rs543874 and rs10938397, the observed effects on BMI
were slightly stronger in AAs than in EA individuals
(change in BMI per coded allele: 1.1% in AAs and 0.9%
in EA individuals for rs543874; 1.0% in AAs and 0.8% in
EAs for rs109383975), whereas they were slightly weaker
in AAs than in EA individuals for rs7647305 (change in
BMI per coded allele: 0.7% in AAs and 0.9% in EA individ-
uals6). The minor-allele frequency (MAF) was higher for
rs543874 and rs7647305 and lower for rs10938397 in
AAs than in EA individuals (Table 1). In the other four
loci, the lead SNPs in AAs differed from the GWAS SNPs
from EA populations. The lead SNPs in all four loci
(rs6548240 in TMEM18, rs2744475 in TFAP2B, rs1519480
in BDNF, and rs6567160 in MC4R) were modestly to
strongly correlated (r2 ranged from 0.5–1.0) with at least
one of the GWAS SNPs on the basis of LD in EA popula-
tions. However, when LD was based on AA populations,
the correlation was weaker, in several cases substantially
weaker (Table 1). For the 13 BMI loci that did not replicate
in our AA analysis, most GWAS index SNPs (13 out of 17)
from previous GWASs involving EA individuals showed
effects in the same direction when results from our AA
samples were compared with results from the previous
EA studies.
We investigated the question of whether LD patterns in
AA studies can narrow previous association signals from EA
studies and found that at seven out of the eight significant
loci, AA LD patterns assisted with narrowing association
signals (Table 2; see also Figure S1). One of the most
extreme examples was for MC4R. Among EA individuals,
107 and 119 SNPs were correlated (r2 > 0.5) with the lead
SNP in our analysis (rs6567160) and with the GWAS index
SNPs, respectively; these SNPs represent a region spanning
184 kb and 230 kb, respectively. However, among AAs only
five SNPs were correlated with rs6567160 at r2 > 0.5, and
these SNPs represented a region spanning 71 kb. In
SEC16B, ETV5, TFAP2B, BDNF, and FTO, the number ofan Journal of Human Genetics 93, 661–671, October 3, 2013 665
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666 The American Journal of Human Genetics 93, 661–671, OctoberSNPs correlated at r2>0.5 with the lead SNP and the span-
ning region size were also substantially reduced and to a
limited degree for TMEM18 (Table 2). Only for GNPDA2
did the number of correlated SNPs and the spanning re-
gion size not reduce, but the number of correlated SNPs
in Europeans was already small.
To further refine the regions associated with BMI in AAs,
we performed conditional analyses for each of the eight
significant loci by including the lead SNP in a locus as a
covariate to search for additional independent signals.
rs186117327 in GNPDA2was borderline significantly asso-
ciated with BMI when the locus-specific significance level
was taken into account (Table 3). No evidence of het-
erogeneity was observed across studies. In GNPDA2,
rs186117327 was significantly associated with BMI in the
marginal analysis (p ¼ 3.7 3 107),; this association
became less significant but remained marginally so when
adjustment was made for the lead SNP (p ¼ 1.7 3 104).
rs186117327 was weakly correlated with the lead SNP
(rs10938397) as well as with the GWAS SNP at this locus
(r2 ¼ 0.11 in AAs; 0.16 in EA individuals).
Identification of Two BMI-Related Loci in AAs by
Metabochip-wide Analysis
In the Metabochip-wide analysis (excluding the SNPs in
the 21 BMI-related loci), we identified five SNPs in two
loci (these SNPs were rs116612809, rs114584581,
rs74941130, and rs79329695 in 2p23.2/BRE [MIM
610497] and rs4802349 in 19q13.32/DHX34) as being
associated with BMI in AAs at a Metabochip-wide signifi-
cance level (p < 2.5 3 107). Two of the SNPs in 2p23.2/
BRE (rs116612809 and rs79329695) reached the conven-
tional genome-wide significance level (p < 5.0 3 108)
(Table 4 and Figure 1). Furthermore, with p ¼ 3.7 3 107,
rs57813622 at the 7p21.2/DGKB [MIM 604070] locus ap-
proached the Metabochip-wide significance level.
In 2p23.2/BRE, all four SNPs are rare variants in Euro-
peans (MAF ¼ 0.1% in the 1000 Genomes Project) but
common in AAs (MAF ¼ 10%). The most significant SNP,
rs116612809, is located in the intronic region of BRE and
is highly correlated with the three other significant SNPs
(r2 ranges from 0.98–1.00, Figure 2). In the conditional
analysis for all other SNPs at the BRE locus, we did not
observe evidence for an additional independent signal
associated with BMI after conditioning on rs116612809,
suggesting that all four SNPs point to the same functional
variant. The 2p23.2/BRE was included on the Metabochip
as a part of a ~1.3-Mb-long region so that a GWAS locus
associated with blood triglyceride (TG) concentrations
could be fine-mapped.24,25 Within this region, the four
BMI-associated SNPs were more than 500 kb away from
the TG GWAS index SNPs (rs1260326, rs1260333,
rs780093, and rs780094; r2 ranged from 0.02–0.05 in
AAs). To examine the association between rs116612809
and blood TG concentrations in our population, we used
ARIC and WHI, for which the TG individual data were
available (n ¼ 11,680). We did not observe a significant3, 2013
Table 3. Conditional Analysis Showing a Locus with Evidence of Second Independent BMI Association Signals in African Americans
Region Gene SNP Position
Number of
Tested SNPs Coded Allele CAF
Marginal Resultsa Conditional Resultsb
r2 with Lead SNP in AAsEffect p Value Het pd Effect p Value Het p
4p12 GNPDA2 rs186117327 45,101,187 285 A 0.75 0.0095 3.7 3 107 0.54 0.0074 1.7 3 104 0.91 0.11
- - rs10938397c 45,182,527 - A 0.75 0.0099 1.7 3 107 0.24 0.0068 1.6 3 103 0.37 -
aMarginal results represent results when only the single variant was in the model.
bConditional analysis represents the result for the SNP when adjustment was made for the most significant lead SNP and vice versa.
cThe most significant SNP in a locus.
dHet p: heterogeneity-test p value.
Table 4. Two BMI Loci Identified in African Americans on the Basis of Metabochip-wide Analysis
Region SNP Position Candidate Gene Coded Allele CAF in AAs
CAF in EA
Individuals Effect p value Rsqa Het p
r2 with Lead
SNP in AAs
2p23.2 rs116612809 28,301,171 BRE A 0.90 0.001 0.0151 3.6 3 108 0.99 0.48 -
- rs114584581 28,304,380 BRE A 0.10 0.001 0.0148 5.9 3 108 0.99 0.43 0.98
- rs74941130 28,306,293 BRE A 0.10 0.001 0.0148 6.9 3 108 0.99 0.44 1.00
- rs79329695 28,319,874 BRE A 0.10 0.001 0.0151 3.7 3 108 0.99 0.56 0.99
19q13.32 rs4802349 47,874,510 DHX34 A 0.48 0.12 0.0087 1.2 3 107 1.00 0.46 -
aMeasurement of imputation accuracy, ranging from 0 (low) to 1 (high).
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Figure 1. Manhattan Plot for Metabo-
chip-Wide Analysis of BMI in African
Americans
The –log10 of p values for each SNP on the
Metabochip is plotted against physical
chromosomal positions. Green dots repre-
sent the SNPs in 21 BMI-related loci that
were previously identified in European
populations and fine-mapped on the
Metabochip. Blue line: p ¼ 2.5 3 107;
red line: p ¼ 5 3 108.association (p ¼ 0.71) with blood TG concentrations,
which did not change after adjustment for BMI. Further-
more, the association between rs116612809 and BMI did
not change after adjustment for TG (Table S4).
In 19q13.32/DHX34, rs4802349 is located in an intron
of DHX34 and has a MAF of 0.48 in AAs and 0.12 in EA
individuals. Only ten SNPs surrounding rs4802349
(5200 kb) were genotyped; none was correlated with
rs4802349 in Aas, and none was associated with BMI. Pre-
viously, rs4802349 was reported to be a putative associa-
tion signal for high-density lipoprotein (HDL) cholesterol
at a moderate p value of 0.005.26 We examined the associ-
ation between rs4802349 and blood HDL concentrations
with and without BMI adjustment in ARIC and WHI
(n ¼ 11,680). We observed that the p value changed
from 0.25 to 0.04 after BMI adjustment. Furthermore, the
association between rs4802349 and BMI did not change
after adjustment for HDL (Table S4).
Sex-Stratification Analyses
We did not observe any additional loci when we stratified
the analysis by sex (Tables S5 and S6 and Figures S2
and S3). Also, the results for the SNPs that were significant
in the fine-mapping analyses and the two BMI loci results
were consistent across sex (p-heterogeneity R 0.29,
Table S7). However, as a result of the relatively small sam-
ple of men in this study, we have limited power to detect
a difference-of-sex effect.
Functional Annotation
In silico analysis assessed whether each BMI-associated
locus was in an ‘‘open,’’ transcriptionally permissive
conformation, as would be expected of a functional locus.
Using ENCODE data sets, we found each signal to be in a
region consistent with regulatory evidence, such as active
histone marks, open chromatin structure (DNase hyper-
sensitivity), or regions experimentally shown to bind one
or more transcription factors (Table S8). Bioinformatics
analyses revealed that the lead SNP, rs6548240 in the
TMEM18 locus, was the strongest functional candidate.668 The American Journal of Human Genetics 93, 661–671, October 3, 2013rs6548240 is in a region of open chro-
matin that binds multiple transcrip-
tion factors, and elevated levels of
active histone marks associated with
promoters were detected in severalcell lines (Figure S4). The functional properties of
TMEM18 are obscure, although a recent study indicated
that TMEM18 plays a regulatory role in adipocyte dif-
ferentiation and biology.27 For GNPDA2, the potential
additional independent signal rs186117327 could be
tagging rs7659184 (r2 ¼ 0.6 with rs186117327 in AAs),
which falls in a region of open chromatin, and relative to
the reference allele, the alternate allele reduces the binding
affinity of GATA2 and EN1 transcription factors. In 2p23.2/
BRE, bioinformatics analyses indicated that the lead
SNP, rs116612809, tags another intronic SNP, rs78003529
(r2 ¼ 0.65 in AAs), which falls in a region of open chro-
matin with elevated enhancer histone marks and is in a
region that binds both Pol2 and c-Jun. Furthermore, evi-
dence from scans of positional weight matrices (PWMs)
suggests that the alternate allele of rs78003527 has a
much higher binding affinity for Nkx3 and Nkx2. In
19q13.32/DHX34, the DHX34 signal rs4802349 and two
SNPs highly correlated with it are located within putative
regulatory regions. rs4802349 falls within histone-modifi-
cation marks associated with enhancer activity and alters
the Mtf1 transcription-factor binding motif. In addition,
two other functional candidates, rs2547369 and
rs2341878 (r2 ¼ 0.7 and 0.6, respectively in African popu-
lations) were highly correlated with this signal and fall in
regions of open chromatin having methylation patterns
associated with promoter or enhancer activity. Further-
more, rs25476369 (r2 ¼ 0.65 with rs4802349 in African
populations) falls in a region that binds six transcription
factors, whereas rs2341878 is of particular interest because
it falls in a strong promoter region in a number of relevant
tissues. The function of GNPDA2, BRE, and DHX34 is un-
known, which makes it difficult to link the underlying bio-
logical mechanisms of these genetic variants to BMI.Discussion
In this study, encompassing close to 30,000 AAs, we used
the Metabochip to systematically evaluate 21 BMI loci
Figure 2. Regional-Association Plot for
the New BMI-Related Locus at 2p23.2/BRE
The –log10 of p values (left y axis) is
plotted against the SNP genomic position
based on NCBI build 37 (x axis); the esti-
mated recombination rate from the 1000
Genomes Project for African populations
is on the right y axis and is plotted in
blue. The most significant SNP is denoted
with a purple diamond. SNPs are colored
to reflect correlation with the most signifi-
cant SNP. Gene annotations are from the
UCSC Genome Browser.discovered among European descent populations in
previous GWASs and to search for potential BMI loci. Eight
of the 21 loci (SEC16B, TMEM18, ETV5, GNPDA2, TFAP2B,
BDNF, FTO, and MC4R) were found to be associated with
BMI in our AA study population. Further conditional ana-
lyses indicated that GNPDA2 contained an additional in-
dependent signal. Moreover, Metabochip-wide analyses
revealed two BMI-associated loci: the BRE locus at
genome-wide significance (p < 5 3 108) and the DHX34
locus at Metabochip-wide significance (p < 2.5 3 107).
Among the eight BMI loci that were significant in the AA
population, the lead SNPs in SEC16B, ETV5, and GNPDA2
were the same as the GWAS SNPs identified in previous EA
studies, which provided further support for the idea that
the three SNPs (rs543874, rs7647305, and rs10938397)
are proxies of causal variants influencing BMI. The most
significant (lead) SNPs in the other five loci differed from
the previously reported GWAS SNPs, although, as ex-
pected, all were moderately to highly correlated with the
GWAS SNPs in European populations (r2 ranged from 0.5
to 1.0). In TFAP2B and MC4R, the GWAS SNPs were not
significantly associated with BMI in AAs, suggesting that
the lead SNPs in these two loci are better proxies for the un-
derlying functional variants. We showed that the weaker
LD patterns in AA populations than in EA populations
substantially reduced the number of functional-variant
proxies in six of the eight BMI loci that were significant
in AAs (and to a limited extent in TMEM18). Our results
illustrate the important contribution of AAs to systematic
fine-mapping of GWAS loci originally reported in EA pop-
ulations. In addition, the lead SNPs that were either consis-
tent or correlated with the GWAS SNPs at these replicated
loci in EA populations might indicate that EA populations
and AA populations share the underlying causal variants at
these loci.
Bioinformatics analyses revealed that the lead SNP,
rs6548240 in the TMEM18 locus, was the strongestThe American Journal of Human Gefunctional candidate. Although
rs6548240 is located in an intergenic
region 31 kb downstream of
TMEM18, ChIP-seq evidence indi-
cates that CTCF looping might an-
chor this distant putative enhancer
to the promoter of TMEM18. Takentogether, these pieces of evidence make rs6548240 an
interesting functional candidate for future laboratory
follow-up. This example shows that combining fine map-
ping with bioinformatics analysis can help to narrow in
on the putative functional variants for further follow-up
studies.
There are multiple reasons that 13 BMI loci originally
identified in EA populations were not significantly associ-
ated with BMI in this sample of AAs. Limited statistical
power could be an important reason for this observation.
Statistical power is impacted by the variance of BMI,
MAF, effect size, and sample size. Compared to populations
in some large European-focused studies, our AA population
had larger variance in BMI7 (standard deviation: 6.2 kg/m2
versus 4.2 kg/m2), which reduces the statistical power. Also
compared with primarily very large European-focused
studies with sample sizes from ~90,000 to ~250,000,5–7
our study was relatively small. Nonreplication might arise
because of different causal variants between EA individuals
and AAs, a weak AA LD pattern, which leads to weak corre-
lation between causal variants and marker SNPs on the
Metabochip, and limited statistical power. All of this might
explain that we did not observe all loci significantly asso-
ciated with BMI in AAs, and it emphasizes the need for
a larger sample size. We used a uniform p value threshold
of 5.8 3 105 (0.05/average number of SNPs per locus)
as an approximate correction for the average of 866 SNPs
across these loci. However, if we use Bonferroni correction
(i.e., 0.05/the number of SNPs at a given locus) or cor-
rection by the effective number of SNPs at each locus after
accounting for LD patterns, one more locus, SH2B1
[MIM 608937], would be indicated to be significant in
AAs (Table S2).
Conditional analysis indicated that the GNPDA2 locus
contained a potential additional independent signal. The
potential additional independent signal, rs186117327,
is physically relatively close (80 kb) to the lead SNP,netics 93, 661–671, October 3, 2013 669
rs10938397, but is only weakly correlated (r2 ¼ 0.11)
with it.
We identified two BMI-related loci, 2p23.2/BRE and
19p13.32/DHX34, in the Metabochip-wide analysis. We
evaluated whether African ancestry plays role in these
two BMI-related loci among 8,310 AAs from a GWAS in
WHI. We didn’t observe a significant effect of ancestry at
these two loci (p > 0.5; Table S9). At 2p23.3/BRE, the
most significant SNP, rs116612809, reached the con-
ventional genome-wide significance level (5 3 108) and
was surrounded (3–18 kb) by three highly correlated
SNPs (r2 ¼ 0.98–1.00) showing very similar results. All
four SNPs are common (MAF ¼ 0.1), but they all are rare
variants in EA populations (MAF ¼ 0.001)28 and hence it
is unlikely that these SNPs would be identified in EA
GWASs unless they have much stronger effects than the
moderate effects observed in our study or are tested in
very large sample sets. The lead SNP in 2p23.3/BRE
(rs116612809) is located within an intron of BRE, which
is stress responsive and highly expressed in brain and
reproductive organs.29 No previous study reported an asso-
ciation with BMI or any other trait; however, in support of
our finding, the GIANTconsortium reported that 82 of 200
SNPs within BRE had a p value< 0.05 (min. p¼ 2.53 104)
for a BMI association in EA populations.5 Accordingly, our
results showed that varying allele frequency in different
ancestral groups significantly contributes to the statistical
power and that studying different ancestral groups helps
to identify potentially functional loci.30
We found another potential BMI-related locus at
19q13.32/DHX34. The SNP rs4802349, located in an
intron DHX34, was marginally significantly associated
with BMI at a Metabochip-wide significance level (p ¼
1.23 107), but because the finding did not reach the con-
ventional genome-wide significance level of 5 3 108,
additional replication studies in AAs are warranted.
DHX34 is a putative RNA helicase and has not been re-
ported to be associated with any diseases or traits in hu-
mans before, except for a suggestive association with
HDL cholesterol (p ¼ 0.005).26 A recent GWAS in EA pop-
ulations showed an association with BMI in a neighboring
region, 19q13.32/ZC3H4; rs3810291 was the most signifi-
cant SNP.5 However, rs4802349 is physically 300 kb away
from rs3810291, and a recombination hotspot lies be-
tween ZC3H4 and DHX34 in AAs and Europeans (HapMap
phase II YRI and CEU), resulting in a low correlation be-
tween both SNPs in African populations (r2 ¼ 0.04) and
Europeans (r2 < 0.001). This observation suggests that
these two associations are independent from each other.
Our results along with the evidence from functional anno-
tation warrant additional validation studies for this locus.
In conclusion, we observed that eight BMI-associated
GWAS loci identified from EA populations were sig-
nificantly associated with BMI in AAs and identified a
potential additional independent signal in one locus. In
addition, we discovered two potential BMI-related loci
through Metabochip-wide analysis; one of these loci670 The American Journal of Human Genetics 93, 661–671, Octoberwhich reached the conventional genome-wide signifi-
cance level. Importantly, our study demonstrated that
fine mapping in AA populations in combination with bio-
informatics analyses is a valuable and effective way to nar-
row in on the underlying causal variants in GWAS loci
discovered in EA populations and that studying minority
populations can contribute to loci discovery.Supplemental Data
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